Recurrent Priapism in a Sickle Cell Disease Patient Treated with Gonadotropin-Releasing Hormone Agonists: A Case Report

    February 2026 in “ The Journal of Sexual Medicine
    A B Pereira de Souza, J G Oliveira Vaz, A Akel Ferruccio, A Salgado Moraes Filho, T Tobias, L Bernardes de Amaro, R Oliveira Lima Silva, L Costa de Salles, V José Massaro Júnior, D Bianqui Guaraldo da Silva, A Canettieri Rubez, R Destro Saad, Adriano Fregonesi
    A 34-year-old male with sickle cell disease experienced recurrent ischemic priapism, unresponsive to standard treatments, including oral etilefrine and bicalutamide. As a last resort before considering penile prosthesis, he was treated with goserelin, a gonadotropin-releasing hormone (GnRH) agonist, which resulted in significant clinical improvement, cessation of stuttering priapism, and recovery of erectile function. The patient opted to continue hormonal therapy, avoiding surgery. This case highlights the potential of GnRH agonists in managing recurrent priapism in sickle cell patients, though long-term safety remains uncertain and warrants further study.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 11 results

    Similar Research

    5 / 1000+ results